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ABSTRACT
Introduction Measuring linkage after community- based 
testing, particularly HIV self- testing (HIVST), is challenging. 
Here, we use data from studies of community- based HIVST 
distribution, conducted within the STAR Initiative, to assess 
initiation of antiretroviral therapy (ART) and factors driving 
differences in linkage rates.
Methods Five STAR studies evaluated HIVST 
implementation in Malawi, Zambia and Zimbabwe. New 
ART initiations during the months of intervention at clinics 
in HIVST and comparison areas were presented graphically, 
and study effects combined using meta- analysis. Meta- 
regression was used to estimate associations between 
the impact of community- based HIVST distribution and 
indicators of implementation context, intensity and reach. 
Effect size estimates used (1) prespecified trial definitions 
of ART timing and comparator facilities and (2) exploratory 
definitions accounting for unexpected diffusion of HIVST 
into comparison areas and periods with less distribution of 
HIVST than was expected.
Results Compared with arms with standard testing only, 
ART initiations were higher in clinics in HIVST distribution 
areas in 4/5 studies. The prespecified meta- analysis 
found positive but variable effects of HIVST on facility 
ART initiations (RR: 1.14, 95% CI 0.93 to 1.40; p=0.21). 
The exploratory meta- analysis found a stronger impact of 
HIVST distribution on ART initiations (RR: 1.29, 95% CI 1.08 
to 1.55, p=0.02).
ART initiations were higher in studies with greater self- 
reported population- level intensity of HIVST use (RR: 
1.12; 95% CI 1.04 to 1.21; p=0.02.), but did not differ 
by national- level indicators of ART use among people 
living with HIV, number of HIVST kits distributed per 1000 
population, or self- reported knowledge of how to link to 
care after a reactive HIVST.
Conclusion Community- based HIVST distribution has 
variable effect on ART initiations compared with standard 
testing service alone. Optimising both support for and 
approach to measurement of effective and timely linkage 
or relinkage to HIV care and prevention following HIVST 
is needed to maximise impact and guide implementation 
strategies.
BACKGROUND
Recent large- scale trials of universal testing- 
and- treatment (UTT) for HIV prevention 
have confirmed that widespread HIV testing 
followed by successful linkage to antiretro-
viral therapy (ART) for persons with an HIV 
diagnosis can reduce HIV transmission across 
the general population.1–5 Biomedical preven-
tion options like pre- exposure prophylaxis 
(PrEP) and voluntary medical male circum-
cision (VMMC) are also highly effective for 
preventing HIV transmission and require 
clients to be linked to additional services 
following an HIV test.6 Universal HIV test 
and treat and biomedical prevention scale- up 
both require that HIV tests be widely available 
across a variety of community- based settings, 
not just within healthcare facilities.3 Linkage 
to care in this context is a multi- step process 
requiring that programmes help users to link 
from testing in the community into health 
facilities to initiate treatment or prevention 
options.7
HIV self- testing (HIVST) is an important 
strategy for expanding the reach of HIV 
testing outside of healthcare facilities, 
and community distribution of HIVST has 
been shown to be particularly effective in 
supporting young people and men who wish 
to test for HIV.8 9 Measuring facility- based 
linkage after community- based testing, partic-
ularly HIVST, is challenging, however, and 
HIVST is less amenable to standard results- 
based cohort analysis due to the intrinsic 
confidentiality of results.10 While self- reports 
suggest that linkage to follow- on care is 
similar following HIVST as for standard HIV 
testing services (HTS), these responses may 
be prone to social desirability bias.10 Data on 
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ART initiations collected from healthcare facilities are 
less susceptible to reporting bias. However, HIVST use 
is not always routinely captured in facility data, making 
it difficult to count users who accessed facility services 
as a result of HIVST. Finally, studies of linkage among 
general populations tend to have small numbers of new 
diagnoses, making robust statistical inference difficult 
as countries approach 90-90-90 targets set by the Joint 
United Nations Programme on HIV/AIDS (UNAIDS).
In this study, we have combined HIVST distribution 
and ART initiation data collected across studies spon-
sored by the STAR Initiative ( hivstar. lshtm. ac. uk). The 
STAR Initiative supported HIVST research and imple-
mentation across in southern Africa, including large 
cluster randomised trials evaluating the effectiveness 
of community HIVST distribution on increasing HIV 
testing coverage and linkage to additional services in 
rural communities in Malawi, Zambia and Zimbabwe. In 
each study, we collected monthly data on ART initiations 
from clinics within communities where HIVST kits were 
distributed and similar data from comparison clinics 
where HIVST was not available. Using the date and 
location of HIVST distribution, we were able to measure 
the increase in ART initiations at clinics during HIVST 
distribution.
This analysis capitalises on the harmonised methods 
and outcomes within STAR, using descriptive analysis, 
meta- analysis and meta- regression to assess patterns of 
linkage over time and to measure whether community- 
based HIVST distribution to users in the general popula-
tion (16 years and older) in three countries in Southern 
Africa was associated with increased ART demand at 
facilities compared with provision of facility- based HTS. 
We also examined the effect of the local testing and 
treatment context, aspects of intervention delivery, and 
whether population members knew where to link to care, 




Only studies funded through the UNITAID/PSI STAR 
Initiative ( hivstar. lshtm. ac. uk) were eligible for inclusion, 
reflecting their common methodologies outlined earlier. 
A systematic review was not conducted, but meta- analysis 
and meta- regression tools were used to pool data across 
eligible STAR studies. Other elements of the meta- analysis 
have been reported using Preferred Reporting Items for 
Systematic Reviews and Meta- Analyses guidelines.11
Within STAR, we used the following inclusion criteria: 
(1) an intervention including the distribution of HIVST 
outside of health facilities to the general adult popula-
tion by lay health workers or community members; (2) 
a prespecified comparison area (either through rando-
misation or not) receiving local standard HTS; (3) study 
outcomes including monthly ART initiation measured 
using facility data.
Five studies from three countries (Malawi, Zambia and 
Zimbabwe) were included in this analysis (table 1), of 
which three were cluster randomised trials that included 
a standard of care arm and two were cluster randomised 
trials comparing two different HIVST distribution strate-
gies that also included non- randomised comparisons of 
ART uptake in clinics from catchment areas where HIVST 
distribution and from clinics where HIVST was not being 
delivered in the catchment area. A study- specific assess-
ment of bias was completed12 (online supplemental table 
1).
HIVST distribution models evaluated in STAR 
included both community- based distribution, in which 
community- based distribution agents (CBDAs) were paid 
to distribute HIVST kits, and community- led (CL) designs 
with greater engagement from community members in 
designing, implementing and overseeing HIVST distribu-
tion and less direct supervision from programme imple-
menters. Duration of distribution ranged from 7 days to 
12 months. In all studies, distributors were trained to 
facilitate correct use of kits and to support users linking 
to health facilities for HIV prevention or care after 
Key questions
What is already known?
 ► Measuring facility- based linkage after community- based HIV self- test 
(HIVST) distribution is challenging because of the inherent confidentiality 
of the HIVST process, and the difficulty of predicting when and where 
HIVST users will link to care.
 ► The STAR Initiative included five large- scale investigations of commu-
nity HIVST distribution, and all included facility- based measurement of 
antiretroviral therapy (ART) initiation. These studies provide a unique op-
portunity to assess ART initiation after HIVST.
What are the new findings?
 ► In some STAR Initiative studies assessing the change in facility ART 
initiations following community HIVST distribution, intervention effects 
seemed to diffuse into areas without HIVST distribution. In others, HIVST 
distribution was not consistent over time, or intervention impacts were 
more brief than expected.
 ► Combining five STAR studies, we found that the impact of HIVST on fa-
cility ART initiations was highly variable. After accounting for unexpected 
diffusion of the intervention into comparison areas and timing of distri-
bution or linkage, there was a clearer positive impact of HIVST on ART 
initiations.
 ► ART initiations were higher in studies where more people self- reported 
using an HIVST during the intervention period. Number of HIVST distrib-
uted per population and knowledge of how to link following HIVST did not 
predict greater ART initiations following HIVST distribution.
What do the new findings imply?
 ► HIVST programmes should consider integrating some measure of pop-
ulation uptake of testing, for example, contacting test users to assess 
whether testing has been used successfully, to help assess the effective-
ness of HIVST in promoting ART initiations.
 ► All STAR Initiative HIVST distribution included support for linkage, but ac-
tual linkage varied across studies, suggesting that there are barriers and 
enablers of linkage across multiple levels of influence. This complexity 
should be considered in programme planning.
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HIVST.8 13 14 All studies were reported using Consolidated 
Standards of Reporting Trials guidelines for reporting of 
cluster randomised trials.15
Outcome measure
Outcomes for all trials included clinical- based ART initi-
ations per month over the intervention period, meas-
ured using medical register data collected from health 
facilities in intervention and comparison areas. In four 
of five trials, data on ART initiations before HIVST distri-
bution were also collected (period ranging from 6 to 
12 months), while one study collected postintervention 
data only. (Data collection is detailed in table 1.) Data on 
whether HIVST were used before the ART initiation were 
not collected in medical registers in study areas and so 
are not available for this analysis.
Published estimates of the increase in ART initiation 
rate during HIVST distribution were included in this 
study. In these published estimates, ART initiations were 
standardised using the number of days on which data 
were collected for studies based in Zimbabwe,13 16 or the 
population of the clinic catchment area for studies based 
in Malawi or Zambia.8 17 18
Descriptive analysis and meta-analysis
For each trial, monthly ART initiation data were graphed 
and trends in both intervention and comparison areas 
were identified. The main meta- analysis combined the 
results of ART initiation analyses from all five trials as 
prespecified in analysis plans finalised before data collec-
tion was complete. A sensitivity meta- analysis included 
the results of exploratory analyses that were presented 
together with the main study findings. These explora-
tory analyses were conducted after data collection was 
complete and accounted for unexpected complications in 
measuring HIVST impact. In these studies, the prespeci-
fied analysis of ART initiations included months in which 
there was less HIVST distribution than expected,17 less 
sustained impact after distribution than expected,8 or 
insufficient distance between HIVST and non- HIVST 
areas leading to likely diffusion of the intervention into 
comparison areas.16 (A complete description of prespec-
ified and exploratory analyses by study is presented in 
table 1.)
MN extracted study- specific rate ratios for outcomes 
reported in the prespecified trial analyses and explor-
atory analyses using monthly level data. Because we 
assumed that the effect of HIVST distribution varied 
based on distribution model and local context, we used 
random effects meta- analysis methods. The meta- analysis 
was conducted using Stata V.16.1,19 with additional visual-
isations completed in R.20
Meta-regression
We used meta- regression to identify factors associated 
of ART uptake following community HIVST distribu-
tion as measured using the prespecified analysis only. 
Meta- regression used the Hartnung and Knapp method 
for adjusting standard errors and test statistics in meta- 
analyses with small numbers of studies.21
Measures used
To understand why HIVST distribution was more effec-
tive at increasing ART initiations in some settings than 
others, we explored key measures of the context of the 
intervention, intervention implementation, and the 
mechanisms of impact that may be associated with inter-
vention success22 (online supplemental figure 1 and 
table 2).
As ART initiations will become more infrequent as 
populations move closer to achieving universal HIV 
testing and treatment, we used Spectrum estimates of 
the proportion of PLHIV that are on ART23 24 (Personal 
communication with A Jahn, 30 September 2020), 
measured as the proportion of PLHIV who know their 
status and are on ART. These are the first two indicators 
of the ‘90-90-90’ target set by UNAIDS shaping national 
HIV testing and treatment strategies.25 We used general 
population estimates for country and year in which all or 
most intervention occurred.
Effectiveness of the HIVST intervention at encour-
aging ART initiations may also be related to the intensity 
of HIVST distribution, and whether the HIVST were used 
by intended populations as expected. Intervention inten-
sity, defined as the number of HIVST kits distributed per 
100 population, was estimated using the count of kits 
distributed by implementing partners and study author 
estimates of adult population size. These data were 
available for four of five studies. Intervention reach was 
measured as the proportion of endline household survey 
participants in intervention areas who self- reported using 
HIVST kits to test for HIV.
Finally, knowledge of how to link to care may be 
important in predicting whether HIVST users go on 
to access ART. We included a measure of knowledge of 
how to link to care following a reactive HIV test result 
to assess whether respondents’ perceived understanding 
of linkage affected intervention outcomes. This was 
measured using endline survey data as the proportion of 
survey participants in HIVST- distribution communities 
who responded positively to a question asking whether 
they knew where to access appropriate follow- up services 
following a positive HIV test.
Patient and public involvement
Communities collaborated in the design of CL inter-
ventions in Zimbabwe and Malawi.8 16 In other studies, 
communities were sensitised to interventions and partic-
ipated in social harms reporting. The public was not 
involved in the analysis of this study.
RESULTS
Descriptive analysis and meta-analysis
In studies in Malawi and Zimbabwe, ART initiations were 
greater in clinics associated with HIVST distribution areas 
during the distribution period, but there was no visual 
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evidence of any difference between HIVST areas over time 
in the Zambia- based study (figure 1). This is consistent 
with the results of prespecified trial analyses for these 
studies, which identified no difference between HIVST 
and non- HIVST areas in Zambia (RR: 0.90; 95% CI 0.55 
to 1.46; p=0.67), but greater ART initiations in HIVST 
areas in all other studies (Malawi CBDA study: RR: 1.34, 
95% CI 0.92 to 1.96, p=0.12; Malawi CL study; RR: 1.31; 
95% CI 0.84 to 2.03, p=0.34; Zimbabwe CBDA study: RR: 
1.27, 95% CI 1.17 to 1.39, p<0.001; Zimbabwe CL study: 
RR: 0.92, 95% CI 0.83 to 1.02, p=0.098) (figure 2).
However, investigating the trajectory of ART initiations 
and HIVST distribution over time shows that these results 
were not consistent across the entire distribution period. 
In several studies, ART initiations increased within the 
first 2 months of distribution and then fall afterward. 
This is particularly pronounced in the Malawi CL study,8 
but also somewhat apparent in the Zimbabwe- based 
studies.13 16 The Malawi community- based distribution 
study8 shows a sharp increase in initiations at the begin-
ning of the distribution period, then sustained increase 
during the second half of the distribution period. The 
data visualisations also show that ART initiations appear 
to be higher in both the HIVST and non- HIVST areas 
in both studies based in Zimbabwe. The increase in ART 
initiations in non- HIVST areas is particularly notice-
able during the Zimbabwe CL distribution, suggesting 
possible diffusion of HIVST into the non- HIVST areas 
with onward effect on ART initiations. Post- hoc analyses 
accounting for these issues have been published,8 13 17 
and generally find a more consistent positive association 
between HIVST distribution and local ART initiations.
In the meta- analysis combining findings of prespecified 
analyses, HIVST distribution in the community was associ-
ated with a 14% increase in ART initiations while distribu-
tion was ongoing (RR: 1.12, 95% CI 0.91 to 1.39; p=0.29; 
figure 2), but with a highly variable strength of association 
as reflected in high I2 (I2=83%). In a sensitivity meta- analysis 
incorporating exploratory analyses accounting for unexpect-
edly low HIVST distribution during parts of the intervention 
period17; lack of sustained impact of intervention8 and diffu-
sion of intervention into comparison areas,16 the effect of 
distribution increases (RR: 1.31, 95% CI 1.19 to 1.43, p<0.001 
I2=40%; figure 2).
Meta-regression
There was no evidence of a difference in the effectiveness 
of HIVST distribution by national- level indicators of ART 
use among PLHIV (10% increase in proportion PLHIV 
on ART: RR: 0.81, 95% CI 0.41 to 1.61, p=0.40; table 3), 
Intensity of HIVST distribution (100 kits per 10 000 resi-
dents) in the population was not associated with effec-
tiveness (RR: 1.14, 95% CI 0.82 to 1.57, p=0.23), nor was 
knowledge of how to link to care following a positive HIV 
test (10% increase, RR: 0.87; 95% CI 0.61 to 1.24; p=0.24).
However, there is a small positive association between 
HIVST distribution and linkage and the percentage of 
survey participants self- reporting using an HIVST during 
the intervention period (10% increase, RR: 1.12; 95% CI 
1.04 to 1.21; p=0.02).
Table 2 Data on intervention context, implementation and mechanisms used in meta- regression analysis
Study author
Country and 
main year of 
implementation
National 
estimates of % 
PLHIV on ART
Total population in 
intervention area
HIVST distributed (total 
and per 1000 residents of 
intervention areas)
Reported 





Know where to 




Malawi, 2017 72.6 Total population: 
93 640 adults; 44 390 in 
intervention area
Total: 220 314 (including 
intervention and other 
distribution areas). No 
population denominator 





Malawi, 2019 78.5 Total population: 84 392 
residents; 44 519 in 
intervention area
Total: 24 316
Per 1000 intervention 
population: 546
74.7† Data not available
Neuman et al18 Zambia, 2017 72.2 Total population: 
308 822; 148 541 in 
intervention area
Total: 65 585
Per 1000 intervention 
population: 442
23.2* 78.7%
Sibanda et al13 Zimbabwe, 2017 67.9 Total population: 
195 076
Total: 80 378
Per 1000 intervention 
population: 412
50.2†* 57.4%
Sibanda et al16 Zimbabwe, 2019 76.5 Total population of 
HIVST wards: 242 096
Total:
59 631
Per 1000 intervention 
population: 246
24.5†* 76.7%
*HIVST uptake ascertained after 12–16 months of continuous distribution.
†HIVST uptake ascertained 3 months after the start of campaign- style distribution.
‡HIVST update ascertained during campaign- style distribution.
ART, antiretroviral therapy; HIVST, HIV self- testing; PLHIV, people living with HIV.
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DISCUSSION
Combining prespecified analyses of ART initiations, we 
found weak evidence of an impact of community- based 
HIVST distribution on linkage to ART in facilities, but 
substantial heterogeneity in effect across studies made 
it difficult to reach a firm conclusion. A combination 
of exploratory results incorporating results reflecting a 
shorter linkage period and diffusion issues resulted in 
a clearer increase in ART initiations following commu-
nity HIV distribution, still with substantial heterogeneity. 
There is strong evidence that HIVST distribution efforts 
that reach eligible populations, as measured using popu-
lation endline survey data, are associated with greater 
facility linkage. However, other measures of context, 
intervention implementation and mechanisms of impact 
are not associated with ART initiation.
Systematic reviews of linkage to care following HIVST 
have found limited but encouraging evidence of 
successful linkage among HIVST users in the general 
population.26–28 A review across community- based HTS 
modes found that linkage was most likely to occur if 
supported by a counsellor.29 Literature on the determi-
nants of linkage to care following HIV testing note that 
multiple levels of influence affect linkage, including 
patient and household- level factors as well as broader 
clinical- level qualities. At the patient and client level, 
perceived stigma and failure to disclose status are barriers 
to linkage.30 Clinical- level factors, including travel time to 
Figure 1 Monthly ART initiations in HIVST distribution and non- HIVST distribution areas. ART, antiretroviral therapy; CBDA, 
community- based distribution agents; HIVST, HIV self- testing; mos, months; SOC, standard of care (no HIVST); w, weeks.
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Figure 2 Meta- analyses of the association between community HIVST distribution and clinic ART initiation using primary 
findings (A) and exploratory analysis findings (B). ART, antiretroviral therapy; HIVST, HIV self- testing.
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clinic, waiting time at clinic, and immediate availability of 
treatment, have also been highlighted as factors encour-
aging linkage following testing29; no information on these 
clinical- level factors were available for these studies. The 
heterogeneity reflected in the findings presented above 
may be caused by a combination of these individual 
and community- level factors mentioned in the litera-
ture, reflecting real differences in the linkage process 
in different places and populations. This highlights the 
complexity of the linkage process and the importance of 
considering linkage over multiple levels, from individual 
to clinic and community, when developing and evalu-
ating testing programmes.
In all studies included in this analysis, ART initia-
tion data were captured10 31 monthly during the period 
of ART initiation: while modelled results presented an 
overall change in ART initiations during the intervention, 
descriptive figures were used to identify when increases 
in ART initiations were largest. The descriptive results 
presented above suggest that there is a distinct uptick in 
ART initiations within weeks or the first month following 
the beginning of HIVST distribution, rather than a 
steady increase over time. This is somewhat different 
from the findings of UTT intervention studies, which 
have defined timely linkage to care as linkage within 6 
months;32 one UTT trial found that around 50% of those 
identified by UTT actually link within 6 months.33 This 
difference in time to linkage between UTT interven-
tions and HIVST distribution may be related to the self- 
directed nature of HIVST uptake. UTT interventions are 
intensive testing programmes designed to find even the 
hardest- to- reach populations, including those who might 
find accessing follow- up care difficult. In contrast, indi-
viduals who take an HIVST from a community distribu-
tion programme may be more ready to test and receive 
treatment quickly. Because the designs used in the STAR 
studies did not follow a cohort of HIVST users through 
the linkage process, it is difficult to disentangle these 
issues here; however, understanding the time to linkage 
is necessary for estimating the public health impact of 
testing interventions on community viral load and HIV 
incidence.
The findings of this analysis have several implications 
for future planning of HIVST programmes. First, when 
assessing intervention implementation, programmes 
should consider integrating some measure of popula-
tion uptake of testing by contacting test users to assess 
whether testing has been used successfully within the 
targeted population. In contrast, measuring the number 
of HIVST distributed is likely to be less useful for assessing 
the success of a programme at linking. The Zambia trial 
findings, in which there was no impact of HIVST distri-
bution on ART initiation, is an example: in this trial, only 
23.2% of household survey respondents reported using 
an HIVST despite substantial numbers of HIVST distrib-
uted, explaining the lack of intervention impact.18 34
Second, programmatic assessments of the capability 
of respondents to link following testing should include 
measures of barriers and enablers of linkage across 
multiple levels of influence. While all HIVST interven-
tions in this meta- analysis included additional support 
for linkage from community- based HIVST distributors 
or community members, there was substantial variation 
across included studies in the proportion of the popula-
tion knowing how to link following HIVST. This indicates 
that, even when support exists, potential users may not be 
aware of support or may face other barriers to successful 
linkage. This is consistent with a previous trial showing 
significant impact on post- test confirmation and ART 
registrations when HIVST was accompanied by a linkage 
intervention of home- based assessment and initiation of 
ART if eligible.35 Finally, recording HIVST use in health 
facility registers would help understand how HIVST users 
access both HIV care and prevention services, and would 
provide additional useful data to further improve HIV 
services. This should be facilitated where possible.31
This study reviewed data collected from five studies 
conducted in three countries as part of the STAR Initia-
tive. The similarity of protocols and distribution models 
across STAR Initiative studies, is a strength of this study, 




95% CI UB P value N (studies)
Context
  Proportion PLHIV on ART (10% change) 0.81 0.41 to 1.61 0.40 5
Intervention delivery
  100 HIVST distributed per 10K population 1.14 0.82 to 1.57 0.23 4
  Proportion taking up HIVST using survey data (10% change) 1.12 1.04 to 1.21 0.02 5
Mechanism of impact
  Proportion knowing where to link with an HIV- positive result (10% change) 0.87 0.61 to 1.24 0.24 4
Number of HIVST distributed per 10 000 population is not available for Indravudh et al,17 and proportion knowing where to link with an HIV- 
positive result is not available for Indravudh et al 2021.8
ART, antiretroviral therapy; HIVST, HIV self- testing; PLHIV, people living with HIV.
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both because these studies particularly suited to pooling, 
and because outcomes and meta- regression predictors 
were measured using similar techniques. These studies 
cover over 615 000 rural residents of Malawi, Zambia and 
Zimbabwe; the size of the combined evaluations is an 
additional strength. The outcome measure used across 
all studies was collected from health facility records, so 
is less prone to social desirability bias than self- reported 
linkage and is an additional study strength.
However, there are several important limitations to this 
study. This study was not based on a systematic review, 
so did not include the universe of HIVST interven-
tions. However, it did include all studies of community- 
based HIVST distribution compared with standard HTS 
among adults during this period in Malawi, Zambia and 
Zimbabwe.28 Other recent reviews of linkage following 
HTS and HIVST that include studies covering a wider 
geography have recently been completed.27 28 Because all 
STAR studies linked community HIVST distribution with 
linkage in nearby health facilities, they have excluded 
individuals who used HIVST and linked at a clinic outside 
their community, as well as users who linked after the end 
of the study. Thus, we assume that our linkage estimates 
underestimate the true number of HIVST users who even-
tually linked to ART. This study does not measure linkage 
to prevention or other HIV services apart from ART initi-
ation, so only accounts for a limited number of actions 
following HIVST. While STAR studies shared similar 
data collection tools and methodologies, the duration 
of HIVST distribution differed across studies, as did the 
number of months of data collected after HIVST distri-
bution began. This makes it difficult to use these data to 
estimate conclusive findings around the amount of time 
required for individuals to link to ART after using HIVST. 
Additional research on how best to support HIVST users 
to link quickly after testing and to understand linkage 
trajectories following HIVST remains necessary.
Additional limitations include the measures of PLHIV who 
are on ART: while national- level estimates were used to calcu-
late this indicator, these likely masks substantial variation in 
testing and treatment uptake by district. Finally, these results 
reflect findings of a small number of studies (N=5) based in 
rural settings in a limited number of countries in Southern 
Africa. These results may not be generalisable across all 
settings in the region, particularly urban areas or areas where 
the characteristics of the HIV epidemic differ.
This study identified a positive but highly variable impact 
of community HIVST distribution on facility ART initiations. 
These results highlight the complexity of measuring linkage 
following community- based HIV testing, and suggest that 
additional linkage strategies may be needed to maximise the 
population benefits of HIV testing.
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